Search

Your search keyword '"Sherry AD"' showing total 461 results

Search Constraints

Start Over You searched for: Author "Sherry AD" Remove constraint Author: "Sherry AD"
461 results on '"Sherry AD"'

Search Results

201. In vivo determination of human breast fat composition by ¹H magnetic resonance spectroscopy at 7 T.

202. Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents.

203. A lanthanide complex with dual biosensing properties: CEST (chemical exchange saturation transfer) and BIRDS (biosensor imaging of redundant deviation in shifts) with europium DOTA-tetraglycinate.

204. Transfer of hyperpolarization from long T1 storage nuclei to short T1 neighbors using FLOPSY-8.

205. T2 exchange agents: a new class of paramagnetic MRI contrast agent that shortens water T2 by chemical exchange rather than relaxation.

206. Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance.

207. Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent.

208. The pH sensitivity of -NH exchange in LnDOTA-tetraamide complexes varies with amide substituent.

209. Could 13C MRI assist clinical decision-making for patients with heart disease?

211. Towards the rational design of MRI contrast agents: δ-substitution of lanthanide(III) NB-DOTA-tetraamide chelates influences but does not control coordination geometry.

212. On-bead combinatorial synthesis and imaging of chemical exchange saturation transfer magnetic resonance imaging agents to identify factors that influence water exchange.

213. Investigations into whole water, prototropic and amide proton exchange in lanthanide(III) DOTA-tetraamide chelates.

214. DNP by thermal mixing under optimized conditions yields >60,000-fold enhancement of 89Y NMR signal.

215. Europium(III) DOTA-derivatives having ketone donor pendant arms display dramatically slower water exchange.

216. The effect of 13C enrichment in the glassing matrix on dynamic nuclear polarization of [1-13C]pyruvate.

217. Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations.

218. Strategies for labeling proteins with PARACEST agents.

219. TmDOTA-tetraglycinate encapsulated liposomes as pH-sensitive LipoCEST agents.

220. Polymeric PARACEST MRI contrast agents as potential reporters for gene therapy.

221. A responsive europium(III) chelate that provides a direct readout of pH by MRI.

222. The population of SAP and TSAP isomers in cyclen-based lanthanide(III) chelates is substantially affected by solvent.

223. 1H MRS of intramyocellular lipids in soleus muscle at 7 T: spectral simplification by using long echo times without water suppression.

224. Multifunctional Polymeric Scaffolds for Enhancement of PARACEST Contrast Sensitivity and Performance: The Effects of Random Copolymer Variations.

225. Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters.

227. Improved synthesis of DOTA tetraamide ligands for lanthanide(III) ions: a tool for increasing the repertoire of potential PARACEST contrast agents for MRI and/or fluorescent sensors.

228. Competition of pyruvate with physiological substrates for oxidation by the heart: implications for studies with hyperpolarized [1-13C]pyruvate.

229. Bimodal MR-PET agent for quantitative pH imaging.

230. A concentration-independent method to measure exchange rates in PARACEST agents.

231. Advantages of macromolecular to nanosized chemical-exchange saturation transfer agents for MRI applications.

232. Hyperpolarized 89Y complexes as pH sensitive NMR probes.

233. A multislice gradient echo pulse sequence for CEST imaging.

234. Lanthanide(III) complexes of tris(amide) PCTA derivatives as potential bimodal magnetic resonance and optical imaging agents.

235. Primer on gadolinium chemistry.

236. Nanoassembled capsules as delivery vehicles for large payloads of high relaxivity Gd3+ agents.

237. Effect of the regiochemistry of butyl amide substituents on the solution-state structures of lanthanide(III) DOTA-tetraamide complexes.

238. A new gadolinium-based MRI zinc sensor.

239. Responsive MRI agents for sensing metabolism in vivo.

240. Modulation of water exchange in Eu(III) DOTA-tetraamide complexes: considerations for in vivo imaging of PARACEST agents.

241. Evidence for reverse flux through pyruvate kinase in skeletal muscle.

242. (S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics.

243. Synthesis and evaluation of lanthanide ion DOTA-tetraamide complexes bearing peripheral hydroxyl groups.

244. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles.

245. Orientation of lipid strands in the extracellular compartment of muscle: effect on quantitation of intramyocellular lipids.

247. Off-resonance saturation magnetic resonance imaging of superparamagnetic polymeric micelles.

248. The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives.

249. Metabolic cycling in control of glucose-stimulated insulin secretion.

250. Imaging the tissue distribution of glucose in livers using a PARACEST sensor.

Catalog

Books, media, physical & digital resources